Search Results | Blood | American Society of Hematology

1-20 of 95

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide for the Treatment of Severe/Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Mohamad Mohty, Didier Blaise, Regis Peffault De Latour, Myriam Labopin, Marie Detrait, Stephane Girault, Anne Huynh, Hélène Labussière-Wallet, Thierry Lamy, Delphine Lebon, Sébastien Maury, Cecile Renard, Kobby Asubonteng, Floriane Delaval, Ibrahim Yakoub-Agha, Jean-Hugues Dalle

Blood (2021) 138 (Supplement 1): 1789.

DOI: https://doi.org/10.1182/blood-2021-147302

Published: 2021

Journal Articles

Outcome of Allogeneic HSCT after Chemo-Based Conditioning in Infants with Acute Myeloid Leukemia in First Complete Remission: A Multicenter EBMT-PDWP Study

Blood (2021) 138 (Supplement 1): 2862.

DOI: https://doi.org/10.1182/blood-2021-145858

Published: 2021

Journal Articles

Clonal Hematopoiesis Driven By MDM4 Amplification Defines a Canonical Route Towards Secondary MDS/AML in Fanconi Anemia Patients

Blood (2021) 138 (Supplement 1): 860.

DOI: https://doi.org/10.1182/blood-2021-147811

Published: 2021

Journal Articles

Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia: Why Do Adolescents and Young Adults Outcomes Differ from Those of Children? a Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Blood (2021) 138 (Supplement 1): 2921.

DOI: https://doi.org/10.1182/blood-2021-146769

Published: 2021

Journal Articles

Post-Transplantation Cyclophosphamide for Gvhd Prophylaxis in Related and Unrelated Allogeneic Hematopoietic Cell Transplantation: Study from the SFGM-TC Registry

Blood (2021) 138 (Supplement 1): 2883.

DOI: https://doi.org/10.1182/blood-2021-151989

Published: 2021

Journal Articles

HLA-Matched Related Hematopoietic Stem Cell Transplantation in Adolescents and Adults with Sickle Cell Disease: Comparison of Myeloablative Versus Non Myeloablative Approaches. Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire

Nathalie Dhedin, Florian Chevillon, Martin Castelle, Virginie Lavoipierre, Jean-Hugues Dalle, Loïc Vasseur, Laure Joseph, Florence Beckerich, Nimrod Buchbinder, Tereza Coman, Frederic Garban, Alina Ferster, Nicolas Boissel, Stephanie Nguyen Quoc, Jean-Benoit Arlet, Corinne Pondarré

Blood (2021) 138 (Supplement 1): 909.

DOI: https://doi.org/10.1182/blood-2021-147052

Published: 2021

Journal Articles

Minimal residual disease quantification in ovarian tissue collected from patients in complete remission of acute leukemia

Florian Chevillon, Emmanuelle Clappier, Chloé Arfeuille, Jean-Michel Cayuela, Jean Hugues Dalle, Rathana Kim, Aurélie Caye-Eude, Céline Chalas, Chrystelle Abdo, Véronique Drouineaud, Régis Peffault de Latour, Marion Alcantara, Madalina Uzunov, Michael Degaud, Véronique Meignin, Hervé Dombret, Nicolas Boissel, Catherine Poirot, Nathalie Dhédin

Blood (2021) 137 (12): 1697–1701.

DOI: https://doi.org/10.1182/blood.2020007782

Published: 2021

Includes: Supplemental data

Journal Articles

Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

Blood (2021) 137 (6): 856–859.

DOI: https://doi.org/10.1182/blood.2020008146

Published: 2021

Includes: Supplemental data

Journal Articles

Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: An International Registry of Childhood Chronic Myeloid Leukemia (I-CML-Ped) Study

Frédéric Millot, Meinolf Suttorp, Stéphanie Ragot, Guy Leverger, MD PhD, Jean-Hugues Dalle, MD PhD, Birgitta Versluijs, Birgitte Lausen, Marina Borisevich

Blood (2020) 136 (Supplement 1): 53–54.

DOI: https://doi.org/10.1182/blood-2020-135844

Published: 2020

Journal Articles

Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study

Alienor Xhaard, MD, Constance Xhaard, Maud D'Aveni, MD, Hélène Salvator, MD PhD, Marie-Laure Chabi-Charvillat, MD, Tereza Coman, MD PhD, Yves Beguin, MD PhD, Yves Chalandon, MD, Xavier Poire, MD, Michael Loschi, MD PhD, Catherine Paillard, MD PhD, Bénédicte Bruno, MD, Patrice Ceballos, MD PhD, Jean-Hugues Dalle, MD PhD, Karin Bilger, MD, Jacques-Olivier Bay, MD PhD, Marie Robin, MD PhD, Stephanie N'guyen-Quoc, MD PhD, Marie Thérèse Rubio, MD PhD

Blood (2020) 136 (Supplement 1): 34.

DOI: https://doi.org/10.1182/blood-2020-138411

Published: 2020

Journal Articles

Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Mohamad Mohty, MD PhD, Ibrahim Yakoub-Agha, Myriam Labopin, MD, Didier Blaise, MD, Delphine Lebon, MD, Virginie Gandemer, MD PhD, Sébastien Maury, Cecile Renard, Charlotte Jubert, Robert J. Ryan, Virginie Bouvatier, Jean-Hugues Dalle, MD PhD, Regis Peffault De Latour, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

DOI: https://doi.org/10.1182/blood-2020-136685

Published: 2020

Journal Articles

Mesenchymal Stromal Cell (MSC) Compassionate Use in France in Treatment of Steroid-Refractory Graft-Versus-Host-Disease (GVHD) after Approval By the Expert Committee of Société Française De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)

Lea Bosdure, Resident, Laurence Blanc, MD, Nimrod Buchbinder, MD, Valerie Coiteux, MD, Gaelle Fossard, MD, Sylvie Francois, MD, Marie Ouachee, MD, Catherine Paillard, MD PhD, Cecile Pochon, MD, Arthur Sterin, MD MSc, Nadine Petitpain, PharmD, Jacques-Olivier Bay, MD PhD, Marie Thérèse Rubio, MD PhD, Danièle Bensoussan, Jean-Hugues Dalle, MD PhD

Blood (2020) 136 (Supplement 1): 26–27.

DOI: https://doi.org/10.1182/blood-2020-142304

Published: 2020

Journal Articles

Impact of Two Different Types of Rabbit ATG on Immune Reconstitution and Overall Results after Allogeneic Hematopoetic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Children

Camille Feltesse, Karima Yakouben, MD, Mony Fahd, MDMSc, Marie Ouachee, MD, Lou le Mouel, MDMSc, Jérôme Le Goff, PharmD, PhD, Guislaine Carcelain, MD PhD, Valérie Guérin, MD MSc, André Baruchel, MD, Sylvie Chevret, MD PhD, Jean-Hugues Dalle, MD PhD

Blood (2020) 136 (Supplement 1): 24–25.

DOI: https://doi.org/10.1182/blood-2020-142374

Published: 2020

Journal Articles

Mesenchymal Stromal Cells (MSCs) Experience in France to Prevent Graft Failure after Hematopoietic Stem Cell Transplantation: A Retrospective Study from the MSCs/CTL Group of the Francophone Society SFGM-TC

Lea Bosdure, Resident, Jean-Hugues Dalle, MD PhD, Catherine Paillard, MD PhD, Mony Fahd, MDMSc, Valerie Coiteux, MD, Nadine Petitpain, PharmD, Danièle Bensoussan, Jacques-Olivier Bay, MD PhD, Marie Thérèse Rubio, MD PhD, Cecile Pochon, MD

Blood (2020) 136 (Supplement 1): 1.

DOI: https://doi.org/10.1182/blood-2020-142334

Published: 2020

Journal Articles

Upfront Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Idiopathic Aplastic Anemia: A Study on Behalf of the Saawp of EBMT

Audrey Françoise Petit, Dirk-Jan Eikema, Alexey Maschan, MD, Dalila Adjaoud, MD, Aleksander Kulagin, Alessandro Rambaldi, MD, Franca Fagioli, MD, Laimonas Griškevičius, MD PhD, John A Snowden, BSc (Hons), MBChB, MD FRCP, FRCPath, Jan-Erik Johansson, MD PhD, Jean-Hugues Dalle, MD PhD, Jenny Byrne, MD PhD, Antonio Risitano, Regis Peffault De Latour, MD PhD

Blood (2020) 136 (Supplement 1): 11–13.

DOI: https://doi.org/10.1182/blood-2020-136657

Published: 2020

Journal Articles

JMML Fetal Identity Results Either from Retention of a Physiologic Signature or Aberrant Activation of Master Oncofetal Regulators

Marion Strullu, MD, Aurélie Caye-Eude, PharmD, PhD, Loïc Maillard, PhD, Chloé Arfeuille, MD, Elodie Lainey, PharmD, PhD, Florian Piques, MD, Odile Fenneteau, PharmD, Bruno Cassinat, PharmD, PhD, Fabien Guimiot, PhD, Jean-Hugues Dalle, MD PhD, André Baruchel, Christine Chomienne, MD PhD, Dominique Bonnet, PhD, Michele Souyri, PhD, Hélène Cavé, PharmD, PhD

Blood (2020) 136 (Supplement 1): 4–5.

DOI: https://doi.org/10.1182/blood-2020-136367

Published: 2020

Journal Articles

Molecular MRD Monitoring Is Feasible in the Majority of Children with AML and Is Highly Predictive of Outcome: Results from the International MyeChild01 Study

Blood (2019) 134 (Supplement_1): 1393.

DOI: https://doi.org/10.1182/blood-2019-125257

Published: 2019

Journal Articles

Immune Reconstitution in 107 Children with Sickle Cell Anemia Transplanted with Bone Marrow or Cord Blood from a Matched-Sibling Donor after Myeloablative Conditioning Regimen Including 20mg/Kg ATG

Francoise Bernaudin, MD, Azadeh Djavidi, MD, Cécile Arnaud, MD, Annie Kamdem, MD, Isabelle Hau, MD, Corinne Pondarré, MD PhD, Jean-Paul Vernant, MD, Mathieu Kuentz, MD, Nathalie Dhedin, MD, Jean-Hugues Dalle, MD PhD, Eliane Gluckman, Gerard Socie, MD PhD

Blood (2019) 134 (Supplement_1): 2253.

DOI: https://doi.org/10.1182/blood-2019-125316

Published: 2019

Journal Articles

Efficacy and Safety of a FLAG-Sequential Regimen Followed By Hematopoietic Stem Cell Transplantation for Myelodysplasia or Acute Leukemia in Fanconi Anemia: A Franco-Brazilian Report

Pierre-Edouard Debureaux, Flore Sicre de Fontbrune, Carmem M. S. Bonfim, MD, Jean-Hugues Dalle, MD PhD, Nimrod Buchbinder, MD, Yves Bertrand, MD, Cecile Renard, MD, Edouard Forcade, MD, Juliana Fernandes, MD, Alexis Talbot, MD, Ricardo Pasquini, MD, Jean Soulier, MD PhD, Thierry Leblanc, MD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2019) 134 (Supplement_1): 2498.

DOI: https://doi.org/10.1182/blood-2019-122007

Published: 2019

Journal Articles

Stenosis Outcome at 1 and 3 Years after Transplantation Vs Standard-Care in Children with Sickle-Cell Anemia and Abnormal Transcranial Doppler with Stroke or No-Stroke History

Blood (2019) 134 (Supplement_1): 2271.

DOI: https://doi.org/10.1182/blood-2019-122699

Published: 2019

2 3 4 5

NARROW

Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide for the Treatment of Severe/Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Outcome of Allogeneic HSCT after Chemo-Based Conditioning in Infants with Acute Myeloid Leukemia in First Complete Remission: A Multicenter EBMT-PDWP Study

Clonal Hematopoiesis Driven By MDM4 Amplification Defines a Canonical Route Towards Secondary MDS/AML in Fanconi Anemia Patients

Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia: Why Do Adolescents and Young Adults Outcomes Differ from Those of Children? a Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Post-Transplantation Cyclophosphamide for Gvhd Prophylaxis in Related and Unrelated Allogeneic Hematopoietic Cell Transplantation: Study from the SFGM-TC Registry

HLA-Matched Related Hematopoietic Stem Cell Transplantation in Adolescents and Adults with Sickle Cell Disease: Comparison of Myeloablative Versus Non Myeloablative Approaches. Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire

Minimal residual disease quantification in ovarian tissue collected from patients in complete remission of acute leukemia

Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: An International Registry of Childhood Chronic Myeloid Leukemia (I-CML-Ped) Study

Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study

Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Mesenchymal Stromal Cell (MSC) Compassionate Use in France in Treatment of Steroid-Refractory Graft-Versus-Host-Disease (GVHD) after Approval By the Expert Committee of Société Française De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)

Impact of Two Different Types of Rabbit ATG on Immune Reconstitution and Overall Results after Allogeneic Hematopoetic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Children

Mesenchymal Stromal Cells (MSCs) Experience in France to Prevent Graft Failure after Hematopoietic Stem Cell Transplantation: A Retrospective Study from the MSCs/CTL Group of the Francophone Society SFGM-TC

Upfront Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Idiopathic Aplastic Anemia: A Study on Behalf of the Saawp of EBMT

JMML Fetal Identity Results Either from Retention of a Physiologic Signature or Aberrant Activation of Master Oncofetal Regulators

Molecular MRD Monitoring Is Feasible in the Majority of Children with AML and Is Highly Predictive of Outcome: Results from the International MyeChild01 Study

Immune Reconstitution in 107 Children with Sickle Cell Anemia Transplanted with Bone Marrow or Cord Blood from a Matched-Sibling Donor after Myeloablative Conditioning Regimen Including 20mg/Kg ATG

Efficacy and Safety of a FLAG-Sequential Regimen Followed By Hematopoietic Stem Cell Transplantation for Myelodysplasia or Acute Leukemia in Fanconi Anemia: A Franco-Brazilian Report

Stenosis Outcome at 1 and 3 Years after Transplantation Vs Standard-Care in Children with Sickle-Cell Anemia and Abnormal Transcranial Doppler with Stroke or No-Stroke History

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only